WallStreetZenWallStreetZen

NASDAQ: PHAT
Phathom Pharmaceuticals Inc Stock Ownership - Who owns Phathom Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Phathom Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Molly HendersonCFO and CBO2024-04-083,435$11.10
$38.13kSell
Terrie CurranPresident and Chief Executive2024-03-2216,851$9.11
$153.51kSell
Takeda Pharmaceutical Co Ltd10% Owner2024-01-243,703,703$8.10
$30.00MSell
Molly HendersonCFO and CBO2024-01-196,307$7.75
$48.90kSell
Molly HendersonCFO and CBO2023-11-202,127$7.24
$15.40kSell
Asit ParikhDirector2023-11-082,500$7.80
$19.50kBuy
Asit ParikhDirector2023-11-074,000$7.76
$31.04kBuy
Asit ParikhDirector2023-11-061,000$8.04
$8.04kBuy
Molly HendersonCFO and CBO2023-11-01811$7.80
$6.33kSell
Molly HendersonCFO and CBO2023-11-0111,681$8.95
$104.54kSell

1 of 2

PHAT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHAT insiders and whales buy or sell their stock.

PHAT Shareholders

What type of owners hold Phathom Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences Management LP17.29%10,109,279$92.80MInstitution
Medicxi Ventures Management Jersey Ltd12.76%7,464,572$68.52MInsider
James N. Topper10.01%5,852,923$53.73MInsider
Frazier Life Sciences Ix LP9.99%5,842,352$53.63MInsider
Medicxi Ventures Management Jersey Ltd6.43%3,760,869$34.52MInstitution
Takeda Pharmaceutical Co Ltd6.42%3,755,583$34.48MInsider
Carlyle Group Inc5.98%3,496,808$32.10MInstitution
Invesco Ltd5.42%3,167,653$29.08MInstitution
Ra Capital Management LP5.33%3,115,008$28.60MInsider
Blackrock Inc4.58%2,678,891$24.59MInstitution

1 of 3

PHAT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHAT60.10%39.90%Net SellingNet Selling
CABA92.00%8.00%Net Buying
PRME32.55%67.45%Net BuyingNet Buying
VALN0.28%0.00%
ORIC70.31%29.69%Net SellingNet Selling
View Top Biotech Stocks

Phathom Pharmaceuticals Stock Ownership FAQ

Who owns Phathom Pharmaceuticals?

Phathom Pharmaceuticals (NASDAQ: PHAT) is owned by 79.78% institutional shareholders, 52.97% Phathom Pharmaceuticals insiders, and 0.00% retail investors. Medicxi Ventures Management Jersey Ltd is the largest individual Phathom Pharmaceuticals shareholder, owning 7.46M shares representing 12.76% of the company. Medicxi Ventures Management Jersey Ltd's Phathom Pharmaceuticals shares are currently valued at $68.52M.

If you're new to stock investing, here's how to buy Phathom Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.